메뉴바로가기 본문바로가기

Program

로케이션 네비게이션

모바일 로케이션 네비게이션

Scientific Program

Scientific Program

  • Level of Difficulty
    • Basic Basic
    • All All
    • Adv Advanced
  • Interactive Interactive Session
  • Breast All English
  • Scientific Session (SS 10) New approaches for breast imaging

    • Sep. 21 (Thu), 08:00-09:20
    • Grand Ballroom 102, 1F
  • Chair(s)

    Hee Jung Shin (Korea) , Mijung Jang (Korea)

  • 08:00-08:10
    Mammographic density changes after neoadjuvant chemotherapy in triple-negative breast cancer: association with treatment and survival outcome

    Yelim Choi (Korea)

  • 08:10-08:20
    Hospital gowns aye or nay: comparison of the impact of medi-robe versus hospital tie-in-the back johnnies (TIBJ) has on patient experience and satisfaction in an outpatient imaging center.

    Pooja Sai Muddana (India)

  • 08:20-08:30
    Correlation of mammography and ultrasonography findings of breast cancer with molecular subtypes

    Atisha Lila (India)

  • 08:30-08:40
    Automated breast ultrasound provides comparable diagnostic performance in opportunistic screening and diagnostic assessment

    Kartini Rahmat (Malaysia)

  • 08:40-08:50
    Non-mass lesions on automated breast ultrasound: imaging findings to predict malignancy and distinguish pseudo-lesions

    Gahyeon Kim (Korea)

  • 08:50-09:00
    Development of fully-automated quantification for breast density and echotexture using AI

    Won Hwa Kim (Korea)

  • 09:00-09:10
    The applications of high-intensity focused ultrasound (HIFU) ablative therapy in the treatment of primary breast cancer: a systematic review

    Dania Zulkifli (Malaysia)

  • Breast All English
  • Scientific Session (SS 12) Artificial intelligence for mammography

    • Sep. 21 (Thu), 09:40-11:00
    • Grand Ballroom 102, 1F
  • Chair(s)

    Eun Young Ko (Korea) , Bong Joo Kang (Korea)

  • 09:40-09:50
    The value of artificial intelligence-based diagnosis on mammograms for predicting axillary LN metastasis in patients with T1-2 invasive breast cancers

    Hyewon Park (Korea)

  • 09:50-10:00
    The role of artificial intelligence-based computer-aided diagnosis for mammography: predicting upstaging in women with biopsy-proven ductal carcinoma in situ

    Ha Jung Kim (Korea)

  • 10:00-10:10
    Performance of artificial intelligence-based diagnosis for depiction of ductal carcinoma In situ on mammograms

    Hyobin Yoon (Korea)

  • 10:10-10:20
    Exploring the potential of Artificial-Intelligence based computer-aid diagnosis for breast cancer on digital mammography in a region without screening program: Insights from the First Study in Hong Kong

    Suet Mui Yu (Hong Kong)

  • 10:20-10:30
    Empowering malaysian breast cancer detection: harnessing AI in screening and diagnostic mammography

    Marlina Tanty Ramli Hamid (Malaysia)

  • 10:30-10:40
    The distribution and positive predictive value of abnormality scores in AI-CAD for mammography

    Si Eun Lee (Korea)

  • 10:40-10:50
    Features of invasive breast cancers missed by artificial intelligence-based computer-assisted diagnosis on mammograms

    Sang-Un Kim (Korea)

  • 10:50-11:00
    Comparable diagnostic performance of artificial intelligence in unilateral mammography to bilateral mammography

    Jiyeong An (Korea)

  • Breast Adv English
  • Scientific Session (SS 04) Breast MRI

    • Sep. 20 (Wed), 09:20-10:30
    • 201, 2F
  • Chair(s)

    Young Mi Park (Korea) , Kyung Hee Ko (Korea)

  • 09:20-09:30
    Advanced second breast cancer in women with or without postoperative surveillance breast MRI: a propensity score-matched analysis

    Jiyoung Yoon (Korea)

  • 09:30-09:40
    Comparison of fat suppression techniques using deep learning-based reconstruction in diffusion-weighted breast MR imaging for the patients with breast cancer

    Jieun Kim (Korea)

  • 09:40-09:50
    Diagnostic efficiency of ultrafast breast MRI in the differentiation of breast lesions

    Yee Voon Wong (Malaysia)

  • 09:50-10:00
    Pretreatment prediction of early clinical response to neoadjuvant chemotherapy using MR imaging features in patients with triple-negative breast cancer

    Hyo-jae Lee (Korea)

  • 10:00-10:10
    Abbreviated breast MRI or digital breast tomosynthesis for breast cancer detection in dense breasts? a retrospective study with comparable results

    Marlina Tanty Ramli Hamid (Malaysia)

  • 10:10-10:20
    Predicting the tumor microenvironment in breast cancer: a single center prospective study using MRI-based intratumoral and peritumoral radiomics

    Hyo Young Kim (Korea)

  • 10:20-10:30
    Imaging phenotype of breast cancer and adjacent parenchymal tissue: correlation with mRNA expression of hormone receptors, HER2 and TP53

    You Na Kim (Korea)

  • Breast Adv English Live
  • Special Focus Session (SF 12) Artificial intelligence in breast imaging: clinical challenges and implications

    • Sep. 22 (Fri), 14:00-15:30
    • Grand Ballroom 103, 1F
  • Chair(s)

    Hye Jung Kim (Korea) , Bo Kyoung Seo (Korea)

  • 14:00-14:30
    AI for breast imaging: current status and future perspectives

    Jung Hyun Yoon (Korea)

  • 14:30-15:00
    Economical impact of AI in breast imaging

    Ki Hwan Kim (Korea)

  • 15:00-15:30
    Ethical and legal challenges on AI in breast imaging

    Linda Moy (USA)

  • Breast All English Live
  • Special Focus Session (SF 02) Risk-based breast cancer screening

    • Sep. 20 (Wed), 16:00-17:30
    • Grand Ballroom 101, 1F
  • Chair(s)

    Sung Hun Kim (Korea) , Ok Hee Woo (Korea)

  • 16:00-16:30
    Risk-based personalized screening: current status and future perspectives

    Kazuaki Nakashima (Japan)

  • 16:30-17:00
    Breast cancer surveillance in women with BRCA mutation

    Su Hyun Lee (Korea)

  • 17:00-17:30
    High-risk screening: abbreviated breast and ultrafast MRI?

    Lars Grimm (USA)

  • Breast All English Live
  • Multidisciplinary Team Session (MDT 05) Rethinking DCIS in a precision medicine era

    • Sep. 22 (Fri), 16:00-17:30
    • Grand Ballroom 103, 1F
  • Chair(s)

    Jung Min Chang (Korea) , Lars Grimm (USA)

  • 16:00-16:30
    Heterogeneity of DCIS: biomarkers for malignant potential and clinical outcome

    Chungyeul Kim (Korea)

  • 16:30-17:00
    DCIS imaging: invasive progression and active surveillance? 

    Lars Grimm (USA)

  • 17:00-17:30
    Management of DCIS: current and future perspectives

    Han-Byoel Lee (Korea)

ALL MENU